Rifabutin Suppresses Inducible Clarithromycin Resistance in <i>Mycobacterium abscessus</i> by Blocking Induction of <i>whiB7</i> and <i>erm41</i>
Clarithromycin (CLR) is the corner stone in regimens for the treatment of lung disease caused by <i>Mycobacterium abscessus (Mab)</i>. However, many strains harbor the CLR-inducible CLR resistance gene <i>erm41,</i> encoding a ribosome methylase. Induction of <i>erm41&l...
| Egile Nagusiak: | , , |
|---|---|
| Formatua: | Artikulua |
| Hizkuntza: | English |
| Argitaratua: |
MDPI AG
2020-02-01
|
| Saila: | Antibiotics |
| Gaiak: | |
| Sarrera elektronikoa: | https://www.mdpi.com/2079-6382/9/2/72 |